Education
About Us
Working with TipRanks
Follow Us
Envoy Medical (COCH)
NASDAQ:COCH
Total Valuation
Envoy Medical has a market cap or net worth of $26.87M. The enterprise value is $44.68M.
Market Cap$26.87M
Enterprise Value$44.68M
Share Statistics
Envoy Medical has 21.33M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21.33M
Owened by Insiders49.74%
Owened by Instutions4.94%
Financial Efficiency
Envoy Medical’s return on equity (ROE) is 16.97 and return on invested capital (ROIC) is -1580.98%.
Return on Equity (ROE)1697.39%
Return on Assets (ROA)-391.47%
Return on Invested Capital (ROIC)-1580.98%
Return on Capital Employed (ROCE)-1829.78%
Revenue Per Employee$8,176.471
Profits Per Employee-$619,352.941
Employee Count34
Asset Turnover0.04
Inventory Turnover0.56
Valuation Ratios
The current PE Ratio of Envoy Medical is -0.76. Envoy Medical’s PEG ratio is -0.01.
PE Ratio-0.76
PS Ratio71.93
PB Ratio-12.90
Price to Fair Value-12.90
Price to FCF-1.28
Price to Operating Cash Flow-1.29
PEG Ratio-0.01
Income Statement
In the last 12 months, Envoy Medical had revenue of $278.00K and earned -$21.06M in profits. Earnings per share was -$1.21.
Revenue$278.00K
Gross Profit-$589.00K
Operating Income-$21.47M
Pretax Income-$21.06M
Net Income-$21.06M
EBITDA-22.31M
Earnings Per Share (EPS)-1.21
Cash Flow
In the last 12 months, operating cash flow was -$25.27M and capital expenditures -$1.53M, giving a free cash flow of -$26.80M billion.
Operating Cash Flow-$25.27M
Free Cash Flow-$26.80M
Free Cash Flow per Share-$1.26
Dividends & Yields
Envoy Medical pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-78.35%
Earnings Yield-131.59%
Stock Price Statistics
Beta0.31
52-Week Price Change-79.08%
50-Day Moving Average1.42
200-Day Moving Average2.13
Relative Strength Index (RSI)38.88
Average Volume (3m)17.43K
Important Dates
Envoy Medical upcoming earnings date is May 14, 2025, Before Open.
Last Earnings DateMar 31, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Envoy Medical as a current ratio of 1.03, with Debt / Equity ratio of -0.32
Current Ratio1.03
Quick Ratio0.82
Debt to Market Cap0.00
Net Debt to EBITDA0.20
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Envoy Medical has paid -$9.28K in taxes.
Income Tax-$9.28K
Effective Tax Rate0.00%
Enterprise Valuation
Envoy Medical EV to EBITDA ratio is -1.05, with an EV/FCF ratio of -1.07.
EV to Sales60.36
EV to EBITDA-1.05
EV to Free Cash Flow-1.07
EV to Operating Cash Flow-1.08
Balance Sheet
Envoy Medical has $4.42M in cash and marketable securities with $15.61M in debt, giving a net cash position of $11.19M billion.
Cash & Marketable Securities$4.42M
Total Debt$15.61M
Net Cash$11.19M
Net Cash Per Share$0.52
Tangible Book Value Per Share-$0.14
Margins
Gross margin is -149.68%, with operating margin of -5813.61%, and net profit margin of -9464.56%.
Gross Margin-149.68%
Operating Margin-5813.61%
Pretax Margin-9464.56%
Net Profit Margin-9464.56%
EBITDA Margin-5771.52%
EBIT Margin-5813.61%
Analyst Forecast
The average price target for Envoy Medical is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside372.44%
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast28.57%
EPS Growth Forecast-656.56%